Fig. 3From: The diagnostic performance of AFP and PIVKA-II models for non-B non-C hepatocellular carcinomaSelection of diagnostic tests by the BMA statistic (A), the performance of optimal model versus individual markers (B), and calibration analysis (C)Back to article page